How long should a thiopental‑induced barbiturate coma be maintained in patients with elevated intracranial pressure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Duration of Thiopental-Induced Coma for Intracranial Hypertension

Thiopental-induced barbiturate coma should be maintained for 3-5 days in most cases of refractory intracranial hypertension, with continuous EEG monitoring targeting burst suppression pattern, and should be discontinued after ICP remains controlled (<20 mmHg) for 24-36 hours.

Treatment Framework

Initial Positioning in Treatment Algorithm

Barbiturate coma is a last-tier therapy for refractory intracranial hypertension, not a first-line treatment 1, 2. It should only be initiated after failure of:

  • Sedation and analgesia
  • Osmotic therapy (mannitol 20% or hypertonic saline at 250 mOsm doses) 3
  • External ventricular drainage (when feasible) 3
  • Optimization of cerebral perfusion pressure (60-70 mmHg) 3

Critical caveat: Barbiturates are ineffective or potentially harmful as prophylactic treatment 1, 2.

Duration Guidelines Based on Evidence

Standard Duration: 3-5 Days

The research evidence consistently demonstrates:

  • Mean treatment duration of 4 days in successful cases 4
  • 1-15 days range reported, with most effective treatments lasting 3-8 days 5, 6
  • Prolonged infusions up to 8-10 days have been used successfully in pediatric cases 7

Discontinuation Criteria

Discontinue barbiturate therapy when:

  • ICP remains <20 mmHg for more than 24-36 hours 6
  • This is the most evidence-based threshold for safe weaning

Early Response Predicts Outcome

A critical prognostic indicator: Patients who do not show immediate ICP response to pentobarbital/thiopental within the first 24 hours universally have poor outcomes 8. This finding suggests:

  • If no ICP control within 24 hours: Consider alternative therapy or palliation
  • If immediate response occurs: Continue therapy with expectation of potentially good functional recovery

Dosing and Monitoring Protocol

Thiopental Administration

  • Loading dose: 5-11 mg/kg IV 5
  • Maintenance infusion: 4-8 mg/kg/hour 5
  • Titration target: ICP <20 mmHg 9, 5

Essential Monitoring Requirements

Cerebral electrical activity must be monitored continuously 1, 2, with:

  • Burst suppression pattern as the physiological endpoint for dose titration
  • This prevents excessive dosing while ensuring adequate cerebral metabolic suppression

ICP monitoring: Calculate the percentage of time ICP remains controlled (<20 mmHg). Patients with ≥88% controlled ICP time have significantly better outcomes compared to those with 68% or less 8.

Common Complications and Management

Barbiturate therapy carries significant risks requiring intensive monitoring 1, 2:

Cardiovascular (Most Common)

  • Hypotension occurs in 58% of patients 5
  • Requires aggressive hemodynamic support with vasopressors
  • Must maintain cerebral perfusion pressure >60 mmHg 3

Metabolic

  • Hypokalemia in 82% 5
  • Requires frequent electrolyte monitoring and replacement

Infectious/Respiratory

  • Respiratory complications in 76% 5
  • Infections in 55% 5
  • These complications were not associated with permanent dysfunction in survivors

Hepatic/Renal

  • Hepatic dysfunction in 87% 5
  • Renal dysfunction in 47% 5

Patient Selection and Prognostic Factors

Favorable Indicators for Treatment

  • Age <60 years 10
  • Initial ICP <40 mmHg when therapy initiated 10
  • Immediate ICP response to barbiturate infusion 8
  • Glasgow Coma Scale >3 10

Poor Prognostic Indicators

  • No response when ICP >40 mmHg at treatment initiation 10
  • Age >60 years 10
  • Lack of early ICP control within first 24 hours 8

Comparison with Decompressive Craniectomy

The RESCUE-ICP study 3 compared barbiturate coma versus decompressive craniectomy for refractory ICP:

  • Mortality: 48.9% with barbiturates vs. 26.9% with craniectomy
  • Favorable outcome at 6 months: 26.6% vs. 27.4% (no significant difference)
  • Severe disability: More common with craniectomy (8.5% vs. 2.1%)

This suggests decompressive craniectomy should be considered before or concurrent with barbiturate therapy in appropriate candidates, particularly younger patients with mass lesions.

Practical Algorithm

  1. Day 0: Initiate thiopental only after failure of first-tier therapies
  2. Hour 0-24: Assess immediate ICP response
    • If no response: Consider alternative therapy or decompressive craniectomy
    • If responsive: Continue therapy
  3. Days 1-3: Maintain burst suppression on EEG, target ICP <20 mmHg
  4. Days 3-5: If ICP controlled for 24-36 consecutive hours, begin weaning
  5. Beyond Day 5: Prolonged therapy (up to 10-15 days) may be necessary in select cases, but reassess prognosis daily

The key principle: Duration is determined by ICP control, not arbitrary time limits, but lack of early response should prompt reconsideration of the treatment plan 6, 8.

References

Guideline

management of severe traumatic brain injury (first 24hours).

Anaesthesia Critical Care & Pain Medicine, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.